Literature DB >> 2357845

IgA subclass antibodies to gliadin in serum and intestinal juice of patients with coeliac disease.

U Volta1, N Molinaro, D Fratangelo, F B Bianchi.   

Abstract

Serum IgA anti-gliadin antibodies (AGA) were positive in 25 (68%) of 37 untreated adults with coeliac disease belonging mostly to IgA1 subclass (88%) and only in a few cases to IgA2 (12%). Antisecretory component IgA AGA were present in serum of seven patients (28%) by immunofluorescence and in nine (36%) by ELISA. The search for IgA AGA in jejunal juice of eight untreated children with coeliac disease was positive in seven cases (88%), with consistent finding of antisecretory component IgA AGA. These antibodies belonged with equal proportion to IgA1 and IgA2 subclasses. This study shows that in intestinal secretions of untreated coeliac disease cases the IgA immune response to gliadin is confined to polymeric anti-secretory component IgA with the same prevalence of IgA1 and IgA2 subclasses, while in serum IgA AGA are largely monomeric, more frequently of IgA1 than of IgA2 subclass, and with a lower proportion of polymeric anti-secretory component IgA (20-36%). The finding of secretory IgA AGA in serum of patients with coeliac disease could result from a spill-over from the intestinal mucosal synthesis into the circulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2357845      PMCID: PMC1535301          DOI: 10.1111/j.1365-2249.1990.tb05232.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues.

Authors:  K Kett; P Brandtzaeg; J Radl; J J Haaijman
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

2.  Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: markers of active childhood and adult coeliac disease.

Authors:  U Volta; M Lenzi; R Lazzari; F Cassani; A Collina; F B Bianchi; E Pisi
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

3.  IgA subclasses in various secretions and in serum.

Authors:  D L Delacroix; C Dive; J C Rambaud; J P Vaerman
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

4.  IgA anti-gliadin antibodies in coeliac disease.

Authors:  D J Unsworth; M Kieffer; E J Holborow; R R Coombs; J A Walker-Smith
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

5.  Distribution of IgA subclasses in sera and bone marrow plasma cells of 21 normal individuals.

Authors:  F Skvaril; A Morell
Journal:  Adv Exp Med Biol       Date:  1974       Impact factor: 2.622

6.  ELISA analysis of IgA subclass antibodies to dietary antigens. Elevated IgA1 antibodies in children with coeliac disease.

Authors:  M Kemp; S Husby; M L Larsen; S E Svehag
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

7.  Serum IgA1 and IgA2 in normal adults and patients with systemic lupus erythematosus and hepatic disease.

Authors:  M E Conley; W J Koopman
Journal:  Clin Immunol Immunopathol       Date:  1983-03

8.  Distribution of IgA 1 and IgA 2 plasma cells in various normal human tissues and in the jejunum of plasma IgA-deficient patients.

Authors:  C André; F André; C Fargier
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

9.  IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease.

Authors:  E Savilahti; M Viander; M Perkkiö; E Vainio; K Kalimo; T Reunala
Journal:  Lancet       Date:  1983-02-12       Impact factor: 79.321

10.  Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A.

Authors:  D L Delacroix; K B Elkom; A P Geubel; H F Hodgson; C Dive; J P Vaerman
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

View more
  8 in total

1.  Class and subclass-associated specificity differences of anti-gliadin antibodies from mucosa and serum.

Authors:  P E Engström; U Sundin; B Lavö; G Norhagen; R Hällgren; C I Smith; L Hammarström
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

2.  IgA antiendomysial antibody test. A step forward in celiac disease screening.

Authors:  U Volta; N Molinaro; M Fusconi; F Cassani; F B Bianchi
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

3.  Early impairment of gut mucosal immunity in HIV-1-infected children.

Authors:  A Quesnel; P Moja; S Blanche; C Griscelli; C Genin
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

4.  Is there IgA of gut mucosal origin in the serum of HIV1 infected patients?

Authors:  A Quesnel; P Moja; F Lucht; J L Touraine; B Pozzetto; C Genin
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

5.  Gut mucosal immunity to tissue transglutaminase in untreated celiac disease and other gastrointestinal disorders.

Authors:  Anna Dahele; Marian C Aldhous; Kathleen Kingstone; Kennneth Humphreys; John Bode; Margaret McIntyre; Subrata Ghosh
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

6.  Serum autoantibodies directed against transglutaminase-2 have a low avidity compared with alloantibodies against gliadin in coeliac disease.

Authors:  K A Gelderman; A C A D Drop; L A Trouw; H J Bontkes; G Bouma; I M W van Hoogstraten; B M E von Blomberg
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

7.  Predictive value for coeliac disease of antibodies to gliadin, endomysium, and jejunum in patients attending for jejunal biopsy.

Authors:  S A McMillan; D J Haughton; J D Biggart; J D Edgar; K G Porter; T A McNeill
Journal:  BMJ       Date:  1991-11-09

8.  Strong Clonal Relatedness between Serum and Gut IgA despite Different Plasma Cell Origins.

Authors:  Rasmus Iversen; Omri Snir; Maria Stensland; José E Kroll; Øyvind Steinsbø; Ilma R Korponay-Szabó; Knut E A Lundin; Gustavo A de Souza; Ludvig M Sollid
Journal:  Cell Rep       Date:  2017-09-05       Impact factor: 9.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.